Timothy Coughlin, CFO at Neurocrine, holds 56.00K shares in aTyr Pharma (Ticker: ATYR), holds 49.00K shares in Travere Therapeutics (Ticker: TVTX), holds 66.28K shares in Fate Therapeutics (Ticker: FATE). Most recently, Timothy Coughlin Bought ― shares of aTyr Pharma on Jun 03, 2024 for an estimated value of 87.50K.
Timothy Coughlin latest transaction was an Informative Buy of $87.50K.
What was Timothy Coughlin's most profitable transaction?
Timothy Coughlin’s most profitable transaction was an Informative Buy of ATYR stock on June 3, 2024. The return on the trade was 81.60%.
What is Timothy Coughlin's role in Neurocrine?
Timothy Coughlin's role in Neurocrine is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.